logo-large
  • Browse Categories

Publications by authors named "Andi Chin"

Claim this Profile
A
A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma.
Bradley McGregor, Daniel M Geynisman, Mauricio Burotto, Cristina Suárez, Maria T Bourlon, Andi Chin

Eur Urol Oncol· June 2023


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hospitalization-Related Costs of Adverse Events for Novel Androgen Receptor Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: An Indirect Comparison.
Neal Shore, Shan Jiang, Viviana Garcia-Horton, Emi Terasawa, David Steffen, Andi Chin

Adv Ther· November 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis.
Andreas Reiter, Jason Gotlib, Iván Álvarez-Twose, Deepti H Radia, Johannes Lübke, Andi Chin

Leukemia· August 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reasons for treatment changes in adults with attention-deficit/hyperactivity disorder: a chart review study.
Jeff Schein, Ann Childress, Martin Cloutier, Urvi Desai, Andi Chin

BMC Psychiatry· June 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: